Jeantet is now active in this space following the arrival of Benjamin May in early 2025 from Aramis. May has strong expertise handling patent litigation, frequently with a cross-border nexus, but he also handles pre-litigation and advisory work. The team has a strong following among clients in the cosmetics, biotech and life sciences sectors.
Legal 500 redaktioneller Kommentar

Kernmandanten

  • Fresenius Medical Care
  • Lanaform
  • Belmoca
  • Arcadophta & BVI France
  • Angus
  • Zentiva (Eli Lilly matter)
  • Preformed Line Products
  • DSM-Firmenich
  • Out & Out Chemistry
  • Ligier

Highlight-Mandate

  • Assisting Fresenius Medical Care in a pan-European litigation against Nipro regarding the infringement and validity of a European patent related to a medical device in the field of dialyzers.
  • Assisted Preformed Line Products in several investigation orders in various locations, as well as enforcing EP patents against competitors on the market of telecoms connectors.
  • Assist DSM-Firmenich specialized in the extraction of biological products and the manufacture of perfumes, against the French company IDCO, suspected to infringe a patent on which DSM-Firmenich holds an exclusive license.

Anwält*innen

Führende Partner*innen

Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.

Praxisleitung

Benjamin May

Weitere Kernanwält*innen

Chloé Chircop